AAAAAA
Results:
1-11
|
Results: 11
Authors:
HERZOG H
ROSCH F
BROCKMANN J
MUHLENSIEPEN H
KOHLE M
STOLZ B
MARBACH P
MULLERGARTNER HW
Citation: H. Herzog et al., QUANTITATIVE-EVALUATION OF Y-90 DOTA-TYR(3)-OCTREOTIDE AS MEASURED INBABOONS BY MEANS OF YTTRIUM-86 AND PET, The Journal of nuclear medicine, 38(5), 1997, pp. 215-215
Authors:
DAMGE C
VONDERSCHER J
MARBACH P
PINGET M
Citation: C. Damge et al., POLY(ALKYL CYANOACRYLATE) NANOCAPSULES AS A DELIVERY SYSTEM IN THE RAT FOR OCTREOTIDE, A LONG-ACTING SOMATOSTATIN ANALOG, Journal of Pharmacy and Pharmacology, 49(10), 1997, pp. 949-954
Authors:
FLOGSTAD AK
HALSE J
BAKKE S
LANCRANJAN I
MARBACH P
BRUNS C
JERVELL J
Citation: Ak. Flogstad et al., SANDOSTATIN LAR IN ACROMEGALIC PATIENTS - LONG-TERM TREATMENT, The Journal of clinical endocrinology and metabolism, 82(1), 1997, pp. 23-28
Authors:
GRASS P
MARBACH P
BRUNS C
LANCRANJAN I
Citation: P. Grass et al., SANDOSTATIN(R) LAR(R) (MICROENCAPSULATED OCTREOTIDE ACETATE) IN ACROMEGALY - PHARMACOKINETIC AND PHARMACODYNAMIC RELATIONSHIPS, Metabolism, clinical and experimental, 45(8), 1996, pp. 27-30
Authors:
LANCRANJAN I
BRUNS C
GRASS P
JAQUET P
JERVELL J
KENDALLTAYLOR P
LAMBERTS SWJ
MARBACH P
ORSKOV H
PAGANI G
SHEPPARD M
SIMIONESCU L
Citation: I. Lancranjan et al., SANDOSTATIN(R) LAR(R) - A PROMISING THERAPEUTIC TOOL IN THE MANAGEMENT OF ACROMEGALIC PATIENTS, Metabolism, clinical and experimental, 45(8), 1996, pp. 67-71
Authors:
KAAL A
FRYSTYK J
SKJAERBAEK C
NIELSEN S
JORGENSEN JOL
BRUNS C
MARBACH P
LANCRANJAN I
WEEKE J
ORSKOV H
Citation: A. Kaal et al., EFFECTS OF INTRAMUSCULAR MICROSPHERE-ENCAPSULATED OCTREOTIDE ON SERUMGROWTH-HORMONE, INSULIN-LIKE GROWTH-FACTORS (IGFS), FREE IGFS, AND IGF-BINDING PROTEINS IN ACROMEGALIC PATIENTS, Metabolism, clinical and experimental, 44(1), 1995, pp. 6-14
Authors:
LANCRANJAN I
BRUNS C
GRASS P
JAQUET P
JERVELL J
KENDALLTAYLOR P
LAMBERTS SWJ
MARBACH P
ORSKOV H
PAGANI G
SHEPPARD M
SIMIONESCU L
Citation: I. Lancranjan et al., SANDOSTATIN LAR(R) - PHARMACOKINETICS, PHARMACODYNAMICS, EFFICACY, AND TOLERABILITY IN ACROMEGALIC PATIENTS, Metabolism, clinical and experimental, 44(1), 1995, pp. 18-26
Authors:
FLOGSTAD AK
HALSE J
HALDORSEN T
LANCRANJAN I
MARBACH P
BRUNS C
JERVELL J
Citation: Ak. Flogstad et al., SANDOSTATIN LAR IN ACROMEGALIC PATIENTS - A DOSE-RANGE STUDY, The Journal of clinical endocrinology and metabolism, 80(12), 1995, pp. 3601-3607
Authors:
STEGEMAN CA
DULLAART RPF
MEIJER S
MARBACH P
SLUITER WJ
Citation: Ca. Stegeman et al., ACUTE RENAL EFFECTS OF SOMATOSTATIN ANALOG, OCTREOTIDE, IN INSULIN-DEPENDENT DIABETIC-PATIENTS - ANTAGONISM BY LOW-DOSE GLUCAGON, Diabetes, nutrition & metabolism, 6(2), 1993, pp. 87-95
Authors:
BRUNS C
STOLZ B
ALBERT R
MARBACH P
PLESS J
Citation: C. Bruns et al., OCTREOSCAN(R)111 FOR IMAGING OF A SOMATOSTATIN RECEPTOR-POSITIVEISLETCELL TUMOR IN RAT, Hormone and Metabolic Research, 27, 1993, pp. 5-11
Authors:
MARBACH P
BRINER U
LEMAIRE M
SCHWEITZER A
TERASAKI T
Citation: P. Marbach et al., FROM SOMATOSTATIN TO SANDOSTATIN(R) - PHARMACODYNAMICS AND PHARMACOKINETICS, Digestion, 54, 1993, pp. 9-13
Risultati:
1-11
|